Brief: Index Pharmaceuticals' Analysis Of CONDUCT Study Confirms Successful Top Line Results, Supports Strategy Going Forward
Feb 19 (Reuters) - InDex Pharmaceuticals Holding AB INDEX.ST :
* INDEX PHARMACEUTICALS' IN-DEPTH ANALYSIS OF THE CONDUCT STUDY CONFIRMS THE SUCCESSFUL TOP
LINE
RESULTS AND SUPPORTS THE STRATEGY GOING FORWARD
* INDEX PHARMACEUTICALS-ANALYSIS CONFIRMS THAT HIGHEST DOSE TESTED, WHICH MET PRIMARY
ENDPOINT,DEMONSTRATES OUTSTANDING COMBINATION OF EFFICACY, SAFETY
Source text for Eikon: ID:nWkr2qtHV4
Further company coverage: INDEX.ST
((Reuters.Briefs@thomsonreuters.com;))